(1995; 156 pages)
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016
(study carried out from April 1993 to February 1994 in 15 importing countries, two exporting countries and two international low-cost essential drugs supply agencies)
Action Programme on Essential Drugs
World Health Organization
Geneva, January 1995
Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developed countries. The DAP research series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. The Action Programme has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by the Programme to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the DAP research series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.
© World Health Organization 1994
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO). The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.
The views expressed in documents by named authors are solely the responsibility of those authors.